ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681239 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681239; 2) Community: the network communities that were significantly associated with the response to NSC 681239; 3) Molecule: the relationships between components within communities and NSC 681239; 4) MDR: the compounds that were significantly associated with the NSC 681239.

NSC Compound Enrichment Correlation
NSC 668814 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative 0.0283958753782624 -0.18719439
NSC 680510 1,8-Naphthyridin-3-amine, 2,7-dichloro-5-methyl- 0.0283958753782624 0.24672824
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.0283958753782624 0.048905454
NSC 692597 Null 0.0283958753782624 -0.15180542
NSC 699666 Null 0.0283958753782624 0.20892663
NSC 709480 Null 0.0283958753782624 0.010714879
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0283958753782624 0.42362215
NSC 687011 stereoisomer of 672120 (MW=262) 0.0284045326811615 0.2391144
NSC 697678 Null 0.0284045326811616 -0.11223814
NSC 700269 1,3-Dioxolo[4,5-g]quinolin-8(5H)-thione, 6-(2-fluorophenyl)- 0.0284045326811616 -0.14596033
Total:63  Current:35    [First] [Prev] [Next] [Last]